Cadence Pharmaceuticals Inc. (CADX) was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up over 103% in the past one-month time frame.
The company has seen a mixed track record when it comes to estimate revisions, of 2 increases and 2 decreases over the past one month, while the Zacks Consensus Estimate has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cadence Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked medical-drugs stocks include BioSpecifics Technologies Corp. (BSTC), Jazz Pharmaceuticals Public Limited Company (JAZZ) and Lannett Company, Inc. (LCI), all of which hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment